<DOC>
	<DOCNO>NCT01413906</DOCNO>
	<brief_summary>The purpose study evaluate tolerability safety profile BMS-833923 ( XL139 ) orally administer daily schedule .</brief_summary>
	<brief_title>Phase 1 Multiple Ascending Dose Study BMS-833923 ( XL139 ) Subjects With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Subjects advance metastatic solid tumor refractory , relapse , standard therapy know effective treatment Men woman , 20 year age Subjects symptomatic brain metastasis active brain metastasis require treatment Inability swallow oral medication Uncontrolled significant cardiovascular disease Inadequate bone marrow function Inadequate hepatic function Inadequate renal function Pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>